The latest coronavirus developments and scientific research on prevention and treatment.
China’s medical products regulator has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the… read more.
Researchers report that hormone replacement therapy is associated with a reduction in COVID-19 mortality. Their findings appeared on May 22, 2022 in Family Practice. “This study supports the… read more.
Automated text messaging was as effective as direct phone calls in getting unvaccinated patients to seek out a COVID-19 shot, according to a new study from the Perelman… read more.
By now, most Americans have felt the effects of global crises on their grocery bills. Recent research published in the journal Nature Food has found this to be a worldwide… read more.
In this first-of-its-kind study, researchers from University College London (UCL) combined multiple NHS datasets on national laboratory testing data, primary care consultations, hospitalisations and deaths to reveal the… read more.
New findings led by researchers at the American Cancer Society (ACS) show the number of women in the United States who reported having a recent (in the past year) breast cancer… read more.
Breakthrough COVID-19 infection is more prevalent among vaccinated cancer patients than in the general population, and the results are more dangerous, researchers reported on April 8, 2022 in… read more.
Throughout the pandemic the University of Huddersfield’s Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they’re an important part of… read more.
Even vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to new… read more.
Deaths involving alcohol use disorder increased dramatically during the pandemic, according to a new study by Cedars-Sinai investigators. The study also found that young adults 25 to 44… read more.
New research being presented at this year’s European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that adults (aged 18 or older) with severe obesity generate… read more.
Investigators report that even though there was some increase in cases of low-severity adverse events after third-dose vaccination against SARS-CoV-2 infection with mRNA vaccines, such third-dose vaccination did… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
